Skip to search formSkip to main contentSkip to account menu

BMY 43351

Known as: BMY-43351, Piperazine, 1-(cyclohexylmethyl)-4-(4-((2,3-dihydro-2-oxo-1H-imidazo(4,5-b)quinolin-7-yl)oxy)-1-oxobutyl)- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesQuinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Antithrombotic activity of BMY-43351, a new imidazoquinoline with enhanced aqueous solubility.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)